Linked Life Data

11907464

Source:http://linkedlifedata.com/resource/pubmed/id/11907464

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-3-21
pubmed:abstractText
Single-agent or combination chemotherapy regimens have not impacted the short median survival of patients with metastatic melanoma, and complete or durable responses are rare. Biologic response modifiers (interferon and interleukin-2) have produced durable remissions in a small cohort of patients, and phase II trials of biochemotherapy suggest more benefit.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1073-2748
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11907464-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11907464-Clinical Trials, Phase II as Topic, pubmed-meshheading:11907464-Clinical Trials, Phase III as Topic, pubmed-meshheading:11907464-Combined Modality Therapy, pubmed-meshheading:11907464-Dose-Response Relationship, Drug, pubmed-meshheading:11907464-Drug Administration Schedule, pubmed-meshheading:11907464-Female, pubmed-meshheading:11907464-Humans, pubmed-meshheading:11907464-Immunologic Factors, pubmed-meshheading:11907464-Male, pubmed-meshheading:11907464-Melanoma, pubmed-meshheading:11907464-Neoplasm Invasiveness, pubmed-meshheading:11907464-Neoplasm Staging, pubmed-meshheading:11907464-Prognosis, pubmed-meshheading:11907464-Retrospective Studies, pubmed-meshheading:11907464-Risk Assessment, pubmed-meshheading:11907464-Skin Neoplasms, pubmed-meshheading:11907464-Survival Analysis, pubmed-meshheading:11907464-Treatment Outcome
pubmed:articleTitle
Metastatic melanoma: chemotherapy to biochemotherapy.
pubmed:affiliation
John Wayne Cancer Institute at St. John's Health Center, Santa Monica, CA 90404, USA. odays@jwci.org
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't